RS4-11
Export
B cell precursor leukemia
Cell Type:
B cell
Tissue Origin:
bone marrow
Species:
human
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:
Suspension
Transfection Information
Lonza Optimized Protocol
Optimization Guideline
Filter:
Any Substrate
Any Platform
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy
to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol
Kit
Program
Cells
Efficiency
Viable Cells
Substrate
Format
Platform
R
T-016
1e6
59%
81%
Plasmid (general)
2 µg
100 µl
I/II/2b
R
T-027
1e6
56%
58%
Plasmid (general)
2 µg
100 µl
I/II/2b
Citations
HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia
Categories:
Transfection
Authors:
Whelan JT, Ludwig DL, Bertrand FE
In:
Leukemia (2008) 22(6): 1161-9
Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity
Categories:
Transfection
Authors:
Hussain SR, Cheney CM, Johnson AJ, Lin TS, Grever MR, Caligiuri MA, Lucas DM, Byrd JC
In:
Clin Cancer Res (2007) 13(7): 2144-50